Patents by Inventor Sandra S. McAllister

Sandra S. McAllister has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210172934
    Abstract: Clonally derived barcoded cell populations and methods of generating the same, as well as methods of use thereof, e.g., to evaluate heterogeneity of a starting population of cells.
    Type: Application
    Filed: December 11, 2020
    Publication date: June 10, 2021
    Inventors: Sandra S. McAllister, Jessica F. Olive
  • Publication number: 20200108066
    Abstract: The present invention is based, in part, on methods for modulating regulatory T cells and immune responses using CDK4/6 inhibitors.
    Type: Application
    Filed: March 28, 2018
    Publication date: April 9, 2020
    Inventors: Shom Goel, Jean Zhao, Flye-Jung Kim, Sandra S. McAllister, Molly DeCristo
  • Patent number: 10295530
    Abstract: Embodiments herein provides an in vitro co-culture system comprising a population of cancer responder cells and a population of non-tumor cells wherein the cancer responder cells can convert to a malignant state and exhibit hallmark malignant phenotype when the cells are placed in a tumor supportive environment. The system is useful for prognosis evaluation of cancer recurrence, malignancy development, cancer drug screening and surveillance for resistance to cancer drug therapy.
    Type: Grant
    Filed: August 14, 2013
    Date of Patent: May 21, 2019
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Sandra S. McAllister, Zafira Castano
  • Publication number: 20150212072
    Abstract: Embodiments herein provides an in vitro co-culture system comprising a population of cancer responder cells and a population of non-tumor cells wherein the cancer responder cells can convert to a malignant state and exhibit hallmark malignant phenotype when the cells are placed in a tumor supportive environment. The system is useful for prognosis evaluation of cancer recurrence, malignancy development, cancer drug screening and surveillance for resistance to cancer drug therapy.
    Type: Application
    Filed: August 14, 2013
    Publication date: July 30, 2015
    Applicant: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Sandra S. Mcallister, Zafira Castano
  • Publication number: 20110206614
    Abstract: The present invention provides tumor instigation systems that can be used to characterize tumor growth and/or metastasis. In some embodiments, the present invention provides a method for studying tumor outgrowth or metastasis including the steps of: (a) providing an animal host; (b) introducing into the animal host one or more cells that instigate the growth of an otherwise indolent tumor; (c) introducing into the animal host a tumor; wherein the presence of the one or more cells or a progeny thereof in the animal host enhances the growth and/or metastasis of the tumor. Among other things, the inventive methods and systems in accordance with the present invention can be used to identify modulators and/or contributors of tumor growth or metastasis, as well as diagnostic and/or therapeutic agents for use in monitoring and/or modulating tumor growth and/or metastasis.
    Type: Application
    Filed: November 26, 2010
    Publication date: August 25, 2011
    Inventors: Sandra S. McAllister, Robert A. Weinberg